Mitoxantrone (novantrone∗) as single agent and in combination chemotherapy in the treatment of advanced breast cancer
- 1 December 1983
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 10, 37-40
- https://doi.org/10.1016/0305-7372(83)90020-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Antitumor activity of mitoxantrone against murine experimental tumors: Comparative analysis against various antitumor antibioticsCancer Chemotherapy and Pharmacology, 1982
- Mitoxantrone: A phase II study in the treatment of patients with advanced breast carcinoma and other solid tumoursCancer Chemotherapy and Pharmacology, 1982
- Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast CancerAnnals of Internal Medicine, 1981
- Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drugCancer Chemotherapy and Pharmacology, 1980
- Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline AntibioticsJournal of Pharmaceutical Sciences, 1979
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977
- Integration of chemotherapy into combined modality treatment of solid tumors: VII. Adenocarcinoma of the breastCancer Treatment Reviews, 1976